Administration of COVID-19 vaccines in immunocompromised patients
Int Immunopharmacol. 2021 Jul 28;99:108021. doi: 10.1016/j.intimp.2021.108021. Online ahead of print.ABSTRACTSince the beginning of vaccination programs against COVID-19 in different countries, several populations such as patients with specific immunological conditions have been considered as the priorities for immunization. In this regard, patients with autoimmune diseases or those receiving immunosuppressive agents and anti-cancer therapies, need special attention. However, no confirmed data is presently available regarding COVID-19 vaccines in these populations due to exclusion from the conducted clinical trials. Given the probable suppression or over-activation of the immune system in such patients, reaching a consensus for their vaccination is critical, besides gathering data and conducting trials, which could probably clarify this matter in the future. In this review, besides a brief on the available COVID-19 vaccines, considerations and available knowledge about administering similar vaccines in patients with cancer, hematopoietic stem cell transplantation, solid organ transplantation, multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatologic and dermatologic autoimmune disorders are summarized to help in decision making. As discussed, live-attenuated viruses, which should be avoided in these groups, are not employed in the present COVID-19 vaccines. Thus, the main concern regarding efficacy could be met using a potent COVID-19 vaccine. Moreover, the...
Source: International Immunopharmacology - Category: Allergy & Immunology Authors: Manica Negahdaripour Mojtaba Shafiekhani Seyed Mohammad Iman Moezzi Sogand Amiri Shiva Rasekh Ashkan Bagheri Pouria Mosaddeghi Afsaneh Vazin Source Type: research
More News: Allergy & Immunology | Autoimmune Disease | Cancer | Cancer & Oncology | Cancer Therapy | Cancer Vaccines | Clinical Trials | COVID-19 | Dermatology | Inflammatory Bowel Disease | Multiple Sclerosis | Rheumatology | Skin | Stem Cell Therapy | Stem Cells | Study | Transplants | Vaccines